More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer

<p><span data-sheets-value= "{"1":2,"2":"<p>This week, we're back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesophageal junction adenocarcinoma, the ClarIDHy study in <i>IDH1</i>-mutated cholangiocarcinoma, and the POLO trial in <i>BRCA</i>-mutated pancreatic cancer.</p><p>To listen to more podcasts from ASCO, visit <a href=\"https://www.asco.org/about-asco/asco-digital/podcasts\">asco.org/podcasts</a>. <br></p>"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we're back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesophageal junction adenocarcinoma, the ClarIDHy study in <em>I</em><em>DH1</em>-mutated cholangiocarcinoma, and the POLO trial in <em>BRCA-</em>mutated pancreatic cancer.</span></p>